CD24 expression is associated with progression of gastric cancer

Hepato-Gastroenterology

Volumn 60, Issue 124, 2013, Pages 653-658

  Takahashi, Masakazu ^a   Nakajima, Masanobu ^a   Ogata, Hideo ^a   Domeki, Yasushi ^a   Ohtsuka, Kichiro ^a   Ihara, Keisuke ^a   Kurayama, Eigo ^a   Onodera, Shinichi ^a   Yamaguchi, Satoru ^a   Sasaki, Kinro ^a   Miyachi, Kazuhito ^a   Kato, Hiroyuki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

CD24; Gastric cancer prognosis; Prognostic marker

Indexed keywords

CD24 ANTIGEN; KI 67 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; TUMOR DIFFERENTIATION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD24; BLOTTING, WESTERN; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; JAPAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84879576847     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12763     Document Type: Article

References (35)

1. Parkin DM, Whelan SL, Ferlay WJ: Cancer incidence in five continents, Vol. VIII. France: International Agency for Research on Cancer (IARC) Scientific Publication No. 155.
2. Statistics and Information Department, Minister's Secretariat. Vital Statistics of Japan 1968-2007 (in Japanese). Tokyo: Ministry of Health, Labour and Welfare.
3. Kristiansen G, Sammar M, Altevogt P: Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 2004; 35:255-262. (Pubitemid 40585311)
4. Sagiv E, Arber N: The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy. Expert Rev Gastroenterol Hepatol 2008; 2:125-133.
5. Baumann P, Cremers N, Kroese F, et al.: CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res 2005; 65:10783-10793. (Pubitemid 41715227)
6. Fischer GF, Majdic O, Gadd S, Knapp W: Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules. J Immunol1990; 144:638-641. (Pubitemid 20036095)
7. Pirruccello SJ, LeBien TW: The human B cell-associated antigen CD24 is a single chain sialoglycoprotein. J Immunol1986; 136:3779-3784. (Pubitemid 16122078)
8. Suzuki T, Kiyokawa N, Taguchi T, et al.: CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system. J Immunol 2001; 166:5567-5577. (Pubitemid 32374179)
9. Kadmon G, von Bohlen und Halbach F, Schachner M, Altevogt P: Differential, LFA-1-sensitive effects of antibodies to nectadrin, the heat-stable antigen, on B lymphoblast aggregation and signal transduction. Biochem Biophys Res Commun 1994; 198:1209-1215. (Pubitemid 24172825)
10. Sammar M, Gulbins E, Hilbert K, et al.: Mouse CD24 as a signaling molecule for integrin-mediated cell binding: functional and physical association with src-kinases. Biochem Biophys Res Commun 1997; 234:330-334. (Pubitemid 27243902)
11. Senner V, Sturm A, Baur I, et al.: CD24 promotes invasion of glioma cells in vivo. J Neuropathol Exp Neurol 1999; 58:795-802. (Pubitemid 29372834)
12. Deng J, Gao G, Wang L, et al.: CD24 expression as a marker for predicting clinical outcome in human gliomas. J Biomed Biotechnol 2012; Article ID517172.
13. Kristiansen G, Winzer KJ, Mayordomo E, et al.: CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 2003; 9:4906-4913. (Pubitemid 37323297)
14. Zarn JA, Zimmermann SM, Pass MK, et al.: Association of CD24 with the kinase c-fgr in a small cell lung cancer cell line and with the kinase lyn in an erythroleukemia cell line. Biochem Biophys Res Commun 1996; 225:384-391. (Pubitemid 26355612)
15. Friederichs J, Zeller Y, Hafezi-Moghadam A, et al.: The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res 2000; 60:6714-6722.
16. Welsh JB, Zarrinkar PP, Sapinoso LM, et al.: Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 2001; 98:1176-1181. (Pubitemid 32121206)
17. Kristiansen G, Pilarsky C, Pervan J, et al.: CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 2004; 58:183-192. (Pubitemid 38160906)
18. Huang LR, Hsu HC: Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res 1995; 55:4717-4721.
19. Sagiv E, Kazanov D, Arber N: CD24 plays an important role in the carcinogenesis process of the pancreas. Biomed Pharmacother 2006; 60:280-284. (Pubitemid 44223938)
20. Sagiv E, Lorenzo M, Karin A, et al.: CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology 2006; 131:630-639. (Pubitemid 44142443)
21. Sano A, Kato H, Sakurai S, et al.: CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma. Ann Surg Oncol 2009; 16:506-514.
22. Aigner S, Sthoeger ZM, Fogel M, et al.: CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 1997; 89:3385-3395. (Pubitemid 27229826)
23. Scholzen T, Gerdes J: The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182:311-322. (Pubitemid 30054364)
24. Lazǎr D, Tǎban S, Sporea I: Ki-67 expression in gastric cancer. Results from a prospective study with long-term follow-up. Rom J Morphol Embryol 2010; 51:655-661.
25. Kain SR, Mai K, Sinai P: Human multiple tissue Western blots: a new immunological tool for the analysis of tissue-specific protein expression. Biotechniques 1994; 17:982-987.
26. Shirasawa T, Akashi T, Sakamoto K, et al.: Gene expression of CD24 core peptide molecule in developing brain and developing non-neural tissues. Dev Dyn 1993; 198:1-13. (Pubitemid 23350239)
27. Magnaldo T, Barrandon Y: CD24 (heat stable antigen, nectadrin), a novel keratinocyte differentiation marker, is preferentially expressed in areas of the hair follicle containing the colony-forming cells. J Cell Sci 1996; 109:3035-3045. (Pubitemid 27029273)
28. Elghetany MT, Patel J: Assessment of CD24 expression on bone marrow neutrophilic granulocytes: CD24 is a marker for the myelocytic stage of development. Am J Hematol 2002; 71:348-349. (Pubitemid 35396958)
29. Sagiv E, Memeo L, Karin A, et al.: CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology 2006; 131:630-639. (Pubitemid 44142443)
30. Athanassiadou P, Grapsa D, Gonidi M, et al.: CD24 expression has a prognostic impact in breast carcinoma. Pathol Res Pract 2009; 205:524-533.
31. Lawson DA, Xin L, Lukacs RU, Cheng D, Witte ON: Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci USA 2007; 104:181-186. (Pubitemid 46068005)
32. Li C, Heidt DG, Dalerba P, et al.: Identification of pancreatic cancer stem cells. Cancer Res 2007; 67:1030-1037.
33. Brabletz T, Jung A, Spaderna S, et al.: Opinion: migrating cancer stem cells: an integrated concept of malignant tumor progression. Nat Rev Cancer 2005; 5:744-749. (Pubitemid 41486367)
34. Taguchi T, Kiyokawa N, Mimori K, et al.: Pre-B cell antigen receptor-mediated signal inhibits CD24-induced apoptosis in human pre-B cells. J Immunol 2003; 170:252-260. (Pubitemid 36026147)
35. Sagiv E, Starr A, Rozovski U, et al.: Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. Cancer Res 2008; 68:2803-2812. (Pubitemid 351556279)